OncoMed Pharmaceuticals, Inc. announced the appointment of Rick Winningham to the company's Board of Directors. Mr. Winningham is currently Chairman and Chief Executive Officer of Theravance Biopharma. Mr. Winningham serves as Chief Executive Officer and Chairman of the Board of Directors of Theravance Biopharma. From 2001-2014 he served as CEO of Theravance, Inc., during which time the company formed a transformational alliance with GlaxoSmithKline, completed a successful initial public offering, and advanced a number of products to commercialization before separating into two independent public companies, Theravance,
Inc. and Theravance Biopharma.